IRTC - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies Inc. (IRTC) | Benzinga

LOS ANGELES, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming April 8, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ:IRTC) common stock between January 11, 2022 and May 30, 2023, inclusive (the "Class Period").

If you suffered a loss on your iRhythm investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/iRhythm-Technologies-Inc-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On November 1, 2022, iRhythm released its revised fourth quarter and full year 2022 financial guidance, issuing an "Advisory Notice" to customers of its real-time heart monitor, Zio AT, and lowered its Zio AT forecast for the quarter from 40% to 20%. On this news, iRhythm's stock price fell $19.67, or 15.5%, over two consecutive trading days to close at $107.10 per share on November 3, 2022, thereby injuring investors.

Then, on November 4, 2022, iRhythm elaborated on its Customer Advisory Notice, revealing that it had initiated it on September 28, 2022 ...

IRTC)>Full story available on Benzinga.com